ArticleEuropean radiology2025
Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab.
Xin Jin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.